4006-776-356 出国就医服务电话

免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / Exercise After Radiation for Head & Neck Cancer

Exercise After Radiation for Head & Neck Cancer

Study Description
Brief Summary:
People who receive radiation therapy for head and neck cancer (HNC) can experience side-effects which include a significant loss in body mass and a loss of muscle mass (cancer cachexia). Some research has shown success in the use of generic (dynamic) resistance training interventions for patients affected by head and neck cancer. However, this approach could be optimized with the use of novel training methods.The primary aim of this research is to investigate the effect of conventional resistance training vs. an experimental intervention (electromyostimulation combined with accentuated eccentric loading) on muscle strength and muscle mass after radiation for HNC.

Condition or disease Intervention/treatment Phase
Head and Neck Neoplasms Behavioral: Accentuated eccentric loading + electromyostimulation Behavioral: Conventional resistance training Not Applicable

Detailed Description:

Background and Rationale

Patients who receive radiation therapy for head and neck cancer treatment are susceptible to side-effects such as a significant loss in body mass and a loss of muscle mass (cancer cachexia) compared to pre-treatment. In addition, radiation therapy treatment may cause cancer-related fatigue and a reduction in overall physical function and health-related quality of life. Some research has shown success in the use of generic (dynamic exercise) resistance training interventions when applied for head and neck cancer survivors. Typically, when the correct training principals are adhered to in healthy populations (i.e. progressive overload, specificity, variation, rest/recovery), muscle strength and muscle mass are effectively enhanced. However, these training variables may be less effective in eliciting positive outcomes in clinical populations in that they are less effective in increasing muscle mass and muscle strength. Exercise is beneficial for people affected by all cancer types, but resistance training may be particularly beneficial for people who have completed radiation therapy treatment for head and neck cancer. Alternative modalities may provide superior improvements in muscle strength and muscle mass. Therefore, further research is warranted to investigate optimized resistance training prescription in head and neck cancer patients.

Research Question & Objectives

The primary aim of this research is to investigate the effect of conventional resistance training vs. an experimental intervention (electromyostimulation combined with accentuated eccentric loading) on muscle strength and muscle mass after radiation for HNC.

Methods

Head and neck cancer survivors who have completed radiation therapy ≥ 1 month and ≤ 1 year from enrollment will be randomly allocated to one of two treatment arms: conventional (active control) and accentuated eccentric loading + electromyostimulation. Participants will be assessed before and after the intervention for patient-reported outcomes, neuromuscular function and fatigability in response to whole-body exercise.

Study Design
Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 22 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Participants are assigned to one of two groups in parallel for the duration of the study
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Eccentric Exercise and Electromyostimulation to Improve Muscle Strength and Muscle Mass After Radiation Therapy for Head and Neck Cancer
Actual Study Start Date : March 31, 2017
Actual Primary Completion Date : June 26, 2019
Estimated Study Completion Date : June 26, 2020
Arms and Interventions
Arm Intervention/treatment
Experimental: Accentuated eccentric loading + electromyostimulation
This group will undertake a supervised 12-week intervention involving accentuated eccentric loading and electromyostimulation of the knee extensors, dynamic resistance training of lower limb antagonist and synergist muscles and upper limb dynamic resistance training.
Behavioral: Accentuated eccentric loading + electromyostimulation
An innovative training intervention to optimize muscle strength and muscle mass

Active Comparator: Traditional resistance training
This group with undertake a supervised 12-week intervention involving volume matched dynamic resistance training of the knee extensors, and dynamic resistance training of lower limb antagonist and synergist muscles and upper limb dynamic resistance training.
Behavioral: Conventional resistance training
A conventional approach to resistance training

Outcome Measures
Primary Outcome Measures :
  1. Maximal Isometric Force in the Knee Extensors [ Time Frame: Baseline and after the 12-week intervention ]
    A change in maximal isometric force in the knee extensors measured before, during and after an intermittent cycling test.

  2. Assessment of change in Muscle Cross-Sectional Area [ Time Frame: Baseline and after the 12-week intervention ]
    ultrasound measurement of the vastus lateralis and rectus femoris


Secondary Outcome Measures :
  1. Assessment of change in the Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-Fatigue) Scale [ Time Frame: Baseline to after the 12-week intervention, at 6 month and 12 month follow up ]
    Self-report questionnaire for the assessment of cancer-related fatigue. This scale is between a possible raw score of 0 - 52, where the higher the number, the better the outcome.

  2. Assessment of change in the Functional Assessment of Chronic Therapy - Head and Neck (FACT-H&N) Scale [ Time Frame: Baseline to after the 12-week intervention, at 6 month and 12 month follow up ]
    Self-report questionnaire for the assessment of quality of life. This scale is between a possible 0 - 144 points, where the higher the number the better the outcome. There are 5 individual sub scales that measure physical-, social-, emotional-, and functional well-being as well as head and neck specific concerns.

  3. Voluntary Activation [ Time Frame: Baseline and after the 12-week intervention ]
    A reduction voluntary activation (using femoral nerve stimulation) measured before, during and after an intermittent cycling test

  4. Potentiated Twitch Force [ Time Frame: Baseline and after the 12-week intervention ]
    A reduction in potentiated quadriceps twitch force measured before, before, during and after an intermittent cycling test.

  5. Muscle Compound Action Potential (M-Wave) Peak-to Peak Amplitude [ Time Frame: Baseline and after the 12-week intervention ]
    evoked from supra-maximal stimulation of the femoral nerve and measured before, during and after an intermittent cycling test

  6. Voluntary Electromyography (EMG) [ Time Frame: Baseline and after the 12-week intervention ]
    Root mean square of the EMG signal during an MVC, measured before, during and after an intermittent cycling test.

  7. Time to volitional exhaustion [ Time Frame: Baseline and after the 12-week intervention ]
    Time to task failure during an intermittent cycling test

  8. Body mass (kg) [ Time Frame: Baseline and after the 12-week intervention ]
  9. Estimated body fat % [ Time Frame: Baseline and after the 12-week intervention ]
    Estimated using skin folds

  10. Body mass index [ Time Frame: Baseline and after the 12-week intervention ]
    Body mass / (height * height)


Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   18 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • a verified clinical diagnosis of head and neck cancer (stage I-IV) with the primary tumor in the oral cavity, pharynx, larynx, paranasal sinuses, or salivary glands.
  • received radiation therapy ± concomitant chemotherapy
  • able to walk without assistance
  • received Canadian Society for Exercise Physiology-Certified Exercise Physiologist (CSEP-CEP) approval via The Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) and/or physician approval
  • willing/able to travel to the University of Calgary (Calgary, AB).

Exclusion Criteria:

  • comorbidities that could confound the ability to participate in laboratory tests (e.g. other malignancies, neuromuscular, musculoskeletal or vascular conditions affecting the lower extremities, such as radiculopathy or myopathy, (where the research team were consulted for individual cases)
  • presence of a percutaneous endoscopic gastrostomy
  • unable to follow verbal instructions in English
Contacts and Locations

Locations
Layout table for location information
Canada, Alberta
Faculty of Kinesiology
Calgary, Alberta, Canada, T2N 1N4
Sponsors and Collaborators
University of Calgary
Investigators
Layout table for investigator information
Principal Investigator: Gui Millet, PhD University of Calgary
Tracking Information
First Submitted Date  ICMJE July 5, 2019
First Posted Date  ICMJE July 9, 2019
Last Update Posted Date July 11, 2019
Actual Study Start Date  ICMJE March 31, 2017
Actual Primary Completion Date June 26, 2019   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: July 9, 2019)
  • Maximal Isometric Force in the Knee Extensors [ Time Frame: Baseline and after the 12-week intervention ]
    A change in maximal isometric force in the knee extensors measured before, during and after an intermittent cycling test.
  • Assessment of change in Muscle Cross-Sectional Area [ Time Frame: Baseline and after the 12-week intervention ]
    ultrasound measurement of the vastus lateralis and rectus femoris
Original Primary Outcome Measures  ICMJE
 (submitted: July 5, 2019)
  • Maximal Isometric Force in the Knee Extensors [ Time Frame: Baseline and after the 12-week intervention ]
    A reduction in maximal isometric force in the knee extensors measured before, during and after an intermittent cycling test.
  • Assessment of change in Muscle Cross-Sectional Area [ Time Frame: Baseline and after the 12-week intervention ]
    ultrasound measurement of the vastus lateralis and rectus femoris
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: July 9, 2019)
  • Assessment of change in the Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-Fatigue) Scale [ Time Frame: Baseline to after the 12-week intervention, at 6 month and 12 month follow up ]
    Self-report questionnaire for the assessment of cancer-related fatigue. This scale is between a possible raw score of 0 - 52, where the higher the number, the better the outcome.
  • Assessment of change in the Functional Assessment of Chronic Therapy - Head and Neck (FACT-H&N) Scale [ Time Frame: Baseline to after the 12-week intervention, at 6 month and 12 month follow up ]
    Self-report questionnaire for the assessment of quality of life. This scale is between a possible 0 - 144 points, where the higher the number the better the outcome. There are 5 individual sub scales that measure physical-, social-, emotional-, and functional well-being as well as head and neck specific concerns.
  • Voluntary Activation [ Time Frame: Baseline and after the 12-week intervention ]
    A reduction voluntary activation (using femoral nerve stimulation) measured before, during and after an intermittent cycling test
  • Potentiated Twitch Force [ Time Frame: Baseline and after the 12-week intervention ]
    A reduction in potentiated quadriceps twitch force measured before, before, during and after an intermittent cycling test.
  • Muscle Compound Action Potential (M-Wave) Peak-to Peak Amplitude [ Time Frame: Baseline and after the 12-week intervention ]
    evoked from supra-maximal stimulation of the femoral nerve and measured before, during and after an intermittent cycling test
  • Voluntary Electromyography (EMG) [ Time Frame: Baseline and after the 12-week intervention ]
    Root mean square of the EMG signal during an MVC, measured before, during and after an intermittent cycling test.
  • Time to volitional exhaustion [ Time Frame: Baseline and after the 12-week intervention ]
    Time to task failure during an intermittent cycling test
  • Body mass (kg) [ Time Frame: Baseline and after the 12-week intervention ]
  • Estimated body fat % [ Time Frame: Baseline and after the 12-week intervention ]
    Estimated using skin folds
  • Body mass index [ Time Frame: Baseline and after the 12-week intervention ]
    Body mass / (height * height)
Original Secondary Outcome Measures  ICMJE
 (submitted: July 5, 2019)
  • Assessment of change in the Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-Fatigue) Scale [ Time Frame: Baseline to after the 12-week intervention, at 6 month and 12 month follow up ]
    Self-report questionnaire for the assessment of cancer-related fatigue.
  • Assessment of change in the Functional Assessment of Chronic Therapy - Head and Neck (FACT-H&N) Scale [ Time Frame: Baseline to after the 12-week intervention, at 6 month and 12 month follow up ]
    Self-report questionnaire for the assessment of cancer-related fatigue.
  • Voluntary Activation [ Time Frame: Baseline and after the 12-week intervention ]
    A reduction voluntary activation (using femoral nerve stimulation) measured before, during and after an intermittent cycling test
  • Potentiated Twitch Force [ Time Frame: Baseline and after the 12-week intervention ]
    A reduction in potentiated quadriceps twitch force measured before, before, during and after an intermittent cycling test.
  • Muscle Compound Action Potential (M-Wave) Peak-to Peak Amplitude [ Time Frame: Baseline and after the 12-week intervention ]
    evoked from supra-maximal stimulation of the femoral nerve and measured before, during and after an intermittent cycling test
  • Voluntary Electromyography (EMG) [ Time Frame: Baseline and after the 12-week intervention ]
    Root mean square of the EMG signal during an MVC, measured before, during and after an intermittent cycling test.
  • Time to volitional exhaustion [ Time Frame: Baseline and after the 12-week intervention ]
    Time to task failure during an intermittent cycling test
  • Body mass (kg) [ Time Frame: Baseline and after the 12-week intervention ]
  • Estimated body fat % [ Time Frame: Baseline and after the 12-week intervention ]
    Estimated using skin folds
  • Body mass index [ Time Frame: Baseline and after the 12-week intervention ]
    Body mass / (height * height)
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Exercise After Radiation for Head & Neck Cancer
Official Title  ICMJE Eccentric Exercise and Electromyostimulation to Improve Muscle Strength and Muscle Mass After Radiation Therapy for Head and Neck Cancer
Brief Summary People who receive radiation therapy for head and neck cancer (HNC) can experience side-effects which include a significant loss in body mass and a loss of muscle mass (cancer cachexia). Some research has shown success in the use of generic (dynamic) resistance training interventions for patients affected by head and neck cancer. However, this approach could be optimized with the use of novel training methods.The primary aim of this research is to investigate the effect of conventional resistance training vs. an experimental intervention (electromyostimulation combined with accentuated eccentric loading) on muscle strength and muscle mass after radiation for HNC.
Detailed Description

Background and Rationale

Patients who receive radiation therapy for head and neck cancer treatment are susceptible to side-effects such as a significant loss in body mass and a loss of muscle mass (cancer cachexia) compared to pre-treatment. In addition, radiation therapy treatment may cause cancer-related fatigue and a reduction in overall physical function and health-related quality of life. Some research has shown success in the use of generic (dynamic exercise) resistance training interventions when applied for head and neck cancer survivors. Typically, when the correct training principals are adhered to in healthy populations (i.e. progressive overload, specificity, variation, rest/recovery), muscle strength and muscle mass are effectively enhanced. However, these training variables may be less effective in eliciting positive outcomes in clinical populations in that they are less effective in increasing muscle mass and muscle strength. Exercise is beneficial for people affected by all cancer types, but resistance training may be particularly beneficial for people who have completed radiation therapy treatment for head and neck cancer. Alternative modalities may provide superior improvements in muscle strength and muscle mass. Therefore, further research is warranted to investigate optimized resistance training prescription in head and neck cancer patients.

Research Question & Objectives

The primary aim of this research is to investigate the effect of conventional resistance training vs. an experimental intervention (electromyostimulation combined with accentuated eccentric loading) on muscle strength and muscle mass after radiation for HNC.

Methods

Head and neck cancer survivors who have completed radiation therapy ≥ 1 month and ≤ 1 year from enrollment will be randomly allocated to one of two treatment arms: conventional (active control) and accentuated eccentric loading + electromyostimulation. Participants will be assessed before and after the intervention for patient-reported outcomes, neuromuscular function and fatigability in response to whole-body exercise.

Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:
Participants are assigned to one of two groups in parallel for the duration of the study
Masking: None (Open Label)
Primary Purpose: Treatment
Condition  ICMJE Head and Neck Neoplasms
Intervention  ICMJE
  • Behavioral: Accentuated eccentric loading + electromyostimulation
    An innovative training intervention to optimize muscle strength and muscle mass
  • Behavioral: Conventional resistance training
    A conventional approach to resistance training
Study Arms  ICMJE
  • Experimental: Accentuated eccentric loading + electromyostimulation
    This group will undertake a supervised 12-week intervention involving accentuated eccentric loading and electromyostimulation of the knee extensors, dynamic resistance training of lower limb antagonist and synergist muscles and upper limb dynamic resistance training.
    Intervention: Behavioral: Accentuated eccentric loading + electromyostimulation
  • Active Comparator: Traditional resistance training
    This group with undertake a supervised 12-week intervention involving volume matched dynamic resistance training of the knee extensors, and dynamic resistance training of lower limb antagonist and synergist muscles and upper limb dynamic resistance training.
    Intervention: Behavioral: Conventional resistance training
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Active, not recruiting
Actual Enrollment  ICMJE
 (submitted: July 5, 2019)
22
Original Actual Enrollment  ICMJE Same as current
Estimated Study Completion Date  ICMJE June 26, 2020
Actual Primary Completion Date June 26, 2019   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • a verified clinical diagnosis of head and neck cancer (stage I-IV) with the primary tumor in the oral cavity, pharynx, larynx, paranasal sinuses, or salivary glands.
  • received radiation therapy ± concomitant chemotherapy
  • able to walk without assistance
  • received Canadian Society for Exercise Physiology-Certified Exercise Physiologist (CSEP-CEP) approval via The Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) and/or physician approval
  • willing/able to travel to the University of Calgary (Calgary, AB).

Exclusion Criteria:

  • comorbidities that could confound the ability to participate in laboratory tests (e.g. other malignancies, neuromuscular, musculoskeletal or vascular conditions affecting the lower extremities, such as radiculopathy or myopathy, (where the research team were consulted for individual cases)
  • presence of a percutaneous endoscopic gastrostomy
  • unable to follow verbal instructions in English
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 18 Years to 75 Years   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE Canada
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT04013178
Other Study ID Numbers  ICMJE HREBA.CC-16-0744
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE
Plan to Share IPD: No
Responsible Party Guillaume Millet, University of Calgary
Study Sponsor  ICMJE University of Calgary
Collaborators  ICMJE Not Provided
Investigators  ICMJE
Principal Investigator: Gui Millet, PhD University of Calgary
PRS Account University of Calgary
Verification Date July 2019

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP